Micro Labs Introduces Hypotab for Type 2 Diabetes
Bangalore-based Micro Labs has announced the launch of a new drug Hypotab for diabetic patients who suffer from low blood sugar levels.
The company said that the drug will restore the blood sugar levels back to normal soon after it is consumed and will be provided to low blood sugar patients only after they present a prescription from a qualified doctor.
"Hypotab is meant for type two diabetes patients who suddenly face hypoglycemia (low sugar) in the body and those who take insulin, which makes them prone to develop the symptom. It is the first standardized therapy to treat low blood sugar and manufactured using the advanced technology of AbMax Biotechnology Co Ltd in China, as it offers 20 micron particle size for faster absorption in the body and gives quick relief", Micro Labs vice president B R Srinath said.